ClinicalTrials.Veeva

Menu

Auricular Acupuncture for Chronic Pain and Insomnia

L

Landstuhl Regional Medical Center

Status

Completed

Conditions

Chronic Pain
Insomnia

Treatments

Device: Sterile acupuncture semi-permanent (ASP) gold needles

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT03503695
M-10395

Details and patient eligibility

About

Background: In the U.S. approximately 1.6 million adults use complementary and alternative or integrative medicine therapy for pain and insomnia. However, very few studies have tested the use of auricular acupuncture (AA) using a standard protocol for participants with chronic pain and insomnia.

Objective: To assess the feasibility and acceptability of AA and to evaluate the effectiveness of AA on pain severity score, pain interference score, and insomnia over an 8-day study period.

Subjects: 45 participants who met the eligibility criteria and signed the consent were randomized to either the AA group (AAG) or the usual care control group (CG) on day 4.

Intervention: A standard AA protocol using penetrating semi-permanent acupuncture needles and in-place for up to four days.

Main Outcome Measures: Brief Pain Inventory pain severity and interference scores for pain and Insomnia Severity Index (ISI) for insomnia.

Results: The use of the standard AA protocol in the AAG led to significant within- and between-group reduction in pain severity and interference scores when compared to the CG. Both groups showed within-group decrease in ISI. However, the AAG showed significant between-group reduction in ISI severity and from moderate to sub-threshold insomnia.

Conclusions: AA was found to show effectiveness in the treatment of chronic pain and insomnia. With a heightened focus on the opioid crisis in the U.S., this easy-to-administer protocol can be an option for treatment modality for military beneficiaries with chronic pain and insomnia.

Enrollment

47 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • military beneficiary - active duty, retiree, or dependents

  • between the ages of 18 - 65 years

  • fall under the care of LRMC footprint

  • self-report of insomnia based on established research criteria

  • sleep-onset latency (SOL) or wakefulness after sleep onset of ≥30 minutes;

    • frequency of at least three times a week;
    • duration of ≥3 months;
    • with unrestorative or unrefreshing sleep
  • NRS Pain rating ≥3 (mild to severe level)

  • pain for ≥3 months

  • able to read and understand English

  • for active duty military, an agreement of supervisor

Exclusion criteria

  • hypersensitivity or allergy to gold.
  • pregnancy or plan for future pregnancy during the duration of the study (since the safety of AA in pregnant women has not been established; based on self-report rather than requiring a pregnancy test)
  • ear trauma or unhealed wounds on the ear
  • participation in any other research protocol with a device or drugs
  • piercing or scar tissue in any of the AA point areas
  • working in jobs with variable hours (e.g., shift work)
  • acupuncture treatment within the last 3 months
  • individuals with valvular prosthetics, hemophilia, or currently receiving an anticoagulant.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

47 participants in 2 patient groups

Auricular Acupuncture
Active Comparator group
Description:
Sterile acupuncture semi-permanent (ASP) gold needles will be administered in the following acupuncture points: Cingulate Gyrus, Thalamus point, Omega 2, Point Zero, and Shen Men starting in either ear and alternating left and right until 10 ASP needles are placed. The needles may remain in the AA points for 3-4 days.
Treatment:
Device: Sterile acupuncture semi-permanent (ASP) gold needles
Comparison Group
No Intervention group
Description:
There will be no intervention. The participants will be instructed to return on Day 8.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems